Search

Your search keyword '"Greg Delgoffe"' showing total 17 results
Start Over "Greg Delgoffe" Publication Type News
17 results on '"Greg Delgoffe"'

1. New Cancer Research from University of Pittsburgh Outlined (Abstract A020: Neutralizing oxidative damage at telomeres prevents T cell dysfunction and improves adoptive cell therapy)

Subjects
Oncology, Experimental, T cells -- Research, Cancer -- Prevention -- Research, Telomeres -- Research, Business, Health, Health care industry, University of Pittsburgh
Abstract

2023 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New study results on cancer have been published. According to news reporting originating from the [...]

Published
2023

2. KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards

Subjects
Immunotherapy, B cells, General interest, News, opinion and commentary, University of Pittsburgh. School of Medicine, Memorial Sloan-Kettering Cancer Center
Abstract

PITTSBURGH: KaliVir Immunotherapeutics has issued the following news release: KaliVir Immunotherapeutics, Inc., a biotech company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced that it has appointed the following [...]

Published
2022

3. KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards

Subjects
Immunotherapy, B cells, Business, News, opinion and commentary, University of Pittsburgh. School of Medicine, Memorial Sloan-Kettering Cancer Center
Abstract

Experts in oncology, immunotherapy and oncolytic viruses to help guide KaliVir's development of systemically deliverable oncolytic virus immunotherapies PITTSBURGH, Dec. 13, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3734963-1&h=1649061412&u=https%3A%2F%2Fkalivir.com%2F&a=KaliVir+Immunotherapeutics%2C+Inc., a biotech company developing cutting-edge, [...]

Published
2022

4. Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics

Subjects
Cancer, General interest, News, opinion and commentary
Abstract

PITTSBURGH: Novasenta has issued the following news release: Novasenta Inc., a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, today announced the [...]

Published
2022

5. Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics

Subjects
Cancer -- Care and treatment, Business, News, opinion and commentary
Abstract

PITTSBURGH, July 29, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3606818-1&h=4149629973&u=https%3A%2F%2Fnovasenta.com%2F&a=Novasenta+Inc., a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, today announced the completion of $40 [...]

Published
2022

6. UPMC Launches Novasenta to Develop Targeted Immunotherapy Drugs for Cancer

Subjects
Drug discovery, Immunotherapy, Cancer -- Drug therapy, Business, News, opinion and commentary
Abstract

PITTSBURGH, Aug. 24, 2021 /PRNewswire/ -- As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched Novasenta, a drug discovery [...]

Published
2021

7. CANCER TRICKS IMMUNE CELLS, IMMUNOTHERAPY CAN TAKE ADVANTAGE

Subjects
Immunotherapy, Cancer -- Care and treatment -- Drug therapy, News, opinion and commentary, University of Pittsburgh. School of Medicine
Abstract

PITTSBURGH, PA -- The following information was released by the University of Pittsburgh: A paper published today in Nature shows how chemicals in the areas surrounding tumors--known as the tumor [...]

Published
2021

8. Century Therapeutics Announces Formation of Scientific Advisory Board

Subjects
B cells, Stem cells, Stem cell transplantation, Stem cell research, Cancer treatment, Scientists, Cancer, Cells (Biology), Business, international, Law
Abstract

Century Therapeutics, developer of induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies for cancer, today announced the formation of its Scientific Advisory Board (SAB) to include several renowned experts in [...]

Published
2020

9. Century Therapeutics Announces Formation of Scientific Advisory Board

Subjects
B cells, Stem cells, Stem cell transplantation, Stem cell research, Cancer treatment, Scientists, Cancer, Cells (Biology), General interest, News, opinion and commentary
Abstract

PHILADELPHIA: Century Therapeutics has issued the following press release: -Century Therapeutics, developer of induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies for cancer, today announced the formation of its Scientific [...]

Published
2020

10. Century Therapeutics Announces Formation of Scientific Advisory Board

Subjects
B cells, Stem cells, Stem cell transplantation, Stem cell research, Cancer treatment, Scientists, Cancer, Cells (Biology), Business, Business, international
Abstract

PHILADELPHIA -- Century Therapeutics, developer of induced pluripotent stem cell (iPSC)-derived allogeneic cell therapies for cancer, today announced the formation of its Scientific Advisory Board (SAB) to include several renowned [...]

Published
2020

12. Findings from National Cancer Institute (NCI) Provide New Insights into Solid Cancer (Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy ...)

Subjects
United States. National Cancer Institute -- Conferences, meetings and seminars -- Reports, Immunotherapy -- Conferences, meetings and seminars -- Reports, Cancer -- Conferences, meetings and seminars -- Reports, Workshops (Educational programs) -- Conferences, meetings and seminars -- Reports, Business, Health, Health care industry
Abstract

2021 AUG 3 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on solid cancer. According to news reporting originating from the National [...]

Published
2021

13. Melanoma Research Alliance Announces $11 Million for 26 Grant Awards to Advance Melanoma Research

Subjects
Cancer treatment -- Health aspects, Cancer genetics -- Health aspects, Research funding -- Health aspects, Anopheles, Editors, Biotechnology industry, Health, Science and technology
Abstract

2020 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- With the world's attention focused on the response to COVID-19, the Melanoma Research [...]

Published
2020

14. The Sidney Kimmel Foundation For Cancer Research Announces 2015 Grant Recipients

Subjects
Research scientists, Cancer, Cancer research, Research funding, Business, general
Abstract

(PRWEB) May 21, 2015 The Sidney Kimmel Foundation for Cancer Research has selected the 2015 recipients for the Kimmel Scholar Program. Fifteen research scientists and medical doctors from across the [...]

Published
2015

17. Mechanism offers promising new approach for harnessing the immune system to fight cancer

Subjects
T cells, Immune system, Immunotherapy, Cancer -- Drug therapy, Vaccines, Melanoma -- Drug therapy, Pharmaceuticals and cosmetics industries, Health, Science and technology
Abstract

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- St. Jude Children's Research Hospital scientists have discovered a way to target the immune system to shrink or eliminate [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results